Identification of molecular apocrine breast tumours by microarray analysis.
about
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancerRole of the androgen receptor in breast cancer and preclinical analysis of enzalutamideProlactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancerCopine-III interacts with ErbB2 and promotes tumor cell migrationThe prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancerTargeting androgen receptor in estrogen receptor-negative breast cancerPhase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast CancerPioneer transcription factors: establishing competence for gene expressionGATA-3 maintains the differentiation of the luminal cell fate in the mammary glandGATA-3 links tumor differentiation and dissemination in a luminal breast cancer modelCancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesMechanisms of oestrogen receptor (ER) gene regulation in breast cancerTriple negative breast cancer: looking for the missing link between biology and treatmentsResearch advances of arteminTargeting the androgen receptor in prostate and breast cancer: several new agents in developmentCCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophagesGene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB familyDistinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcomeUtilization of genomic signatures to identify phenotype-specific drugsMolecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapyDo breast cancer cell lines provide a relevant model of the patient tumor methylome?Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesReduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.A comparison of selective classification methods in DNA microarray data of cancer: some recommendations for application in health promotion.Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways.The LeFE algorithm: embracing the complexity of gene expression in the interpretation of microarray dataNectin-4 is a new histological and serological tumor associated marker for breast cancer.A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancersThe removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving meta-analysis and prediction of prognosis.A resampling-based meta-analysis for detection of differential gene expression in breast cancerSelecting control genes for RT-QPCR using public microarray dataMeta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.APRIL is overexpressed in cancer: link with tumor progressionData perturbation independent diagnosis and validation of breast cancer subtypes using clustering and patterns.Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypesAltered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.Comparison study of microarray meta-analysis methods.Dynamism in gene expression across multiple studies.Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.Functional analysis: evaluation of response intensities--tailoring ANOVA for lists of expression subsets
P2860
Q21132473-47003FE0-2FA1-4C4F-B916-AAF9C4B4C9D5Q21195191-94496154-E150-4E39-B3FD-6D9E41CF2168Q21195199-3E116F96-069F-41A4-8428-F418BFFD5132Q22001536-F9B31FBC-6E62-418A-9B52-3D4E84B4B7CCQ24310299-5E936AB3-AC5A-4D74-A00B-D6280CB0AEFFQ24312457-18FDA007-34DC-439A-9E3F-C305BAABC8FCQ24563045-43FACFCA-D740-43F4-A0F9-8C29F49F93C2Q24625373-8CB1753B-FF5A-4F01-BB6D-FE41B1E89ABAQ24649647-93675810-CB18-4C58-A95C-93EA573ACFA8Q24657350-9961C68D-C14A-4EBF-AD66-3F569EDE201CQ26743510-A49E0322-B081-4159-B0DA-F82C65CF9AA3Q26765380-C22E8869-812A-42AC-9D86-602772F05F1DQ26783122-61ED71E1-99C0-427F-9443-6B2205F7F4D0Q26992299-6AFA4D92-9310-498B-A73D-3BA0DCAD90EAQ27009424-90553D1D-1CBF-4BC1-B1A0-A5A648C50061Q27308841-628A12A8-61E8-4233-BA0C-018777DE2EDBQ28258227-681BEA5A-3BDC-4749-A857-01C397729BE3Q28273187-8A5A321F-8F39-4CF1-9BA2-0C1269B99CFCQ28476014-DC809CC1-54A7-45BB-880B-64250F5A0686Q28535227-B7B8503A-DC07-4758-B0E4-B811D28AB666Q28542556-83BEC3E0-9F36-4BDB-AD3D-9BC856CF9ADCQ29617680-B4A16A61-1D02-47AB-B00A-50253CAEAB2FQ30419961-B33E687B-2F7C-4F4E-A307-023D6C90D0EDQ30790659-BA05E46D-9936-47EF-B783-E400393C73C1Q31067183-EA0E9227-9C0B-4B29-AE76-20F2038A78F1Q31127106-AD0D5BE8-7FA3-4C22-98C2-11A123108217Q33283461-720CC2E7-592E-44CA-9A3A-07FBE3E3EB63Q33289245-A9CD50DB-8DAE-416E-B8EC-FEE47C3320F8Q33370712-5C0058AB-A0AE-4D0A-8167-3B1EE918ACE5Q33396580-539E391C-D006-463F-AC20-548C2C86402DQ33404896-E6224E70-766E-41AD-B01E-8A5652192511Q33416006-8E0AE1FC-F142-408C-AF9A-C19369A7BE01Q33418752-1BD10684-4362-4A4A-ACC4-0ACDBEC4E308Q33449315-5CFC8B28-C49F-443F-8D16-92648FEEFBA8Q33608593-F09A64CA-D464-4943-AE5B-A1EA1E725836Q33627153-823303E8-B381-4271-8DF3-E611FF7245F3Q33647460-6092398A-C0E3-4958-A4E1-5603B9A04545Q33675348-9416B327-F011-46B7-B2BD-26DD3C6E71FFQ33712426-EE387C3B-7105-49B4-AD09-D6B3511A76E5Q33717474-6D0B51DE-0209-49C1-8C21-374EDE277B84
P2860
Identification of molecular apocrine breast tumours by microarray analysis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Identification of molecular apocrine breast tumours by microarray analysis.
@en
Identification of molecular apocrine breast tumours by microarray analysis.
@nl
type
label
Identification of molecular apocrine breast tumours by microarray analysis.
@en
Identification of molecular apocrine breast tumours by microarray analysis.
@nl
prefLabel
Identification of molecular apocrine breast tumours by microarray analysis.
@en
Identification of molecular apocrine breast tumours by microarray analysis.
@nl
P2093
P2860
P356
P1433
P1476
Identification of molecular apocrine breast tumours by microarray analysis
@en
P2093
Anne-Laure Nicoulaz
Cathrin Brisken
Darlene Goldstein
David Cameron
Denis Larsimont
Gaetan Macgrogan
Herve Bonnefoi
Jonas Bergh
Maryse Fiche
Mauro Delorenzi
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208561
P407
P50
P577
2005-07-01T00:00:00Z
P5875
P6179
1036436999